EyePoint Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. EyePoint Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 11% to $46,018,000. The net income raised on -$70,795,000 and profit margin reached -154%. Total operating expenses were $115,048,000.
Profit Margin
| 2014 | 3.47M | -13.35M | -384.54% |
|---|---|---|---|
| 2015 | 26.56M | 6.34M | 23.89% |
| 2016 | 1.62M | -21.54M | -1330.06% |
| 2017 | 7.53M | -18.48M | -245.19% |
| 2018 | 2.96M | -53.17M | -1795.71% |
| 2019 | 20.36M | -62.96M | -309.2% |
| 2020 | 34.43M | -52.65M | -152.89% |
| 2021 | 36.93M | -63.91M | -173.03% |
| 2022 | 41.40M | -124.51M | -300.72% |
| 2023 | 46.01M | -70.79M | -153.84% |
EYPT Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 46.01M | 41.40M | 36.93M | 34.43M | 20.36M | 2.96M | 7.53M | 1.62M | 26.56M | 3.47M |
Cost of revenue | 4.63M | 8.32M | 8.17M | 5.82M | 2.68M | 18.50M | 0 | 815K | 14.38M | 78K |
Gross profit | 41.38M | 33.07M | 28.76M | 28.61M | 17.67M | -15.54M | 7.53M | 805K | 12.18M | 3.39M |
Operating exp. | ||||||||||
Research and development | 64.66M | 49.64M | 28.5M | 17.42M | 15.36M | 16.17M | 14.88M | 14.38M | 12.08M | 9.57M |
Selling and marketing | 11.68M | 25.50M | 27.50M | 25.29M | 29.77M | 1.51M | 1.51M | 0 | 0 | 0 |
Total operating expenses | 115.04M | 112.01M | 84.03M | 65.90M | 65.53M | 29.23M | 26.11M | 23.39M | 20.14M | 17.04M |
Operating income | -75.06M | -78.93M | -55.27M | -37.29M | -47.86M | -26.27M | -18.57M | -21.77M | 6.42M | -13.49M |
Other income (expenses), net | 4.35M | -23.31M | -3.14M | -8.10M | -8.93M | -26.27M | -26.89M | 72K | 72K | 22K |
Income before tax | -70.71M | -102.25M | -58.41M | -45.39M | -56.79M | -53.17M | -18.48M | -21.70M | 6.44M | -13.48M |
Income tax expense | 83K | 22.25M | 5.49M | 7.25M | 6.17M | -25.55M | -815K | -155K | 96K | -130K |
Net income | -70.79M | -124.51M | -63.91M | -52.65M | -62.96M | -53.17M | -18.48M | -21.54M | 6.34M | -13.35M |
Earnings per share | ||||||||||
Basic EPS | -1.82 | -3.34 | -2.22 | -4.1 | -6.04 | -11.5 | -5.23 | -6.81 | 2.16 | -4.87 |
Diluted EPS | -1.82 | -3.34 | -2.22 | -4.1 | -6.04 | -11.5 | -5.23 | -6.81 | 2.08 | -4.87 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |